CA9 and breast cancer: Additionally, Rosser et al. showed that a similar protein biomarker panel, namely the previously described 8-protein biomarker panel without CA9, enables the differentiation between BC patients and patients with different urological disorders (74% sensitivity and 90% specificity) [188].